Dexfenfluramine and the Oestrogen-metabolizing Enzyme CYP1B1 in the Development of Pulmonary Arterial Hypertension

Overview

Journal Cardiovasc Res

Specialty Cardiology & Vascular Diseases

Date 2013 Mar 23

PMID 23519266

Citations 34

Authors

Yvonne Dempsie

Neil A MacRitchie

Kevin White

Ian Morecroft

Audrey F Wright

Margaret Nilsen

Lynn Loughlin

Kirsty M Mair

Margaret R MacLean

Affiliations

Soon will be listed here.

Abstract

Aims: Pulmonary arterial hypertension (PAH) occurs more frequently in women than men. Oestrogen and the oestrogen-metabolising enzyme cytochrome P450 1B1 (CYP1B1) play a role in the development of PAH. Anorectic drugs such as dexfenfluramine (Dfen) have been associated with the development of PAH. Dfen mediates PAH via a serotonergic mechanism and we have shown serotonin to up-regulate expression of CYP1B1 in human pulmonary artery smooth muscle cells (PASMCs). Thus here we assess the role of CYP1B1 in the development of Dfen-induced PAH.

Methods And Results: Dfen (5 mg kg(-1) day(-1) PO for 28 days) increased right ventricular pressure and pulmonary vascular remodelling in female mice only. Mice dosed with Dfen showed increased whole lung expression of CYP1B1 and Dfen-induced PAH was ablated in CYP1B1(-/-) mice. In line with this, Dfen up-regulated expression of CYP1B1 in PASMCs from PAH patients (PAH-PASMCs) and Dfen-mediated proliferation of PAH-PASMCs was ablated by pharmacological inhibition of CYP1B1. Dfen increased expression of tryptophan hydroxylase 1 (Tph1; the rate-limiting enzyme in the synthesis of serotonin) in PAH-PASMCs and both Dfen-induced proliferation and Dfen-induced up-regulation of CYP1B1 were ablated by inhibition of Tph1. 17β-Oestradiol increased expression of both Tph1 and CYP1B1 in PAH-PASMCs, and Dfen and 17β-oestradiol had synergistic effects on proliferation of PAH-PASMCs. Finally, ovariectomy protected against Dfen-induced PAH in female mice.

Conclusion: CYP1B1 is critical in the development of Dfen-induced PAH in mice in vivo and proliferation of PAH-PASMCs in vitro. CYP1B1 may provide a novel therapeutic target for PAH.

Citing Articles

Defined Diets Link Iron and α-Linolenic Acid to Cyp1b1 Regulation of Neonatal Liver Development Through Srebp Forms and LncRNA H19.

Jefcoate C, Larsen M, Song Y, Maguire M, Sheibani N Int J Mol Sci. 2025; 26(5).

PMID: 40076634 PMC: 11901102. DOI: 10.3390/ijms26052011.

Overview of Methamphetamine-Associated Pulmonary Arterial Hypertension.

Charoenpong P, Hall N, Keller C, Kumar Ram A, Murnane K, Goeders N Chest. 2024; 165(6):1518-1533.

PMID: 38211700 PMC: 11177101. DOI: 10.1016/j.chest.2024.01.014.

Study on Potential Differentially Expressed Genes in Idiopathic Pulmonary Fibrosis by Bioinformatics and Next-Generation Sequencing Data Analysis.

Giriyappagoudar M, Vastrad B, Horakeri R, Vastrad C Biomedicines. 2023; 11(12).

PMID: 38137330 PMC: 10740779. DOI: 10.3390/biomedicines11123109.

Pulmonary Arterial Hypertension: Emerging Principles of Precision Medicine across Basic Science to Clinical Practice.

Kelly N, Chan S Rev Cardiovasc Med. 2023; 23(11).

PMID: 36875282 PMC: 9980296. DOI: 10.31083/j.rcm2311378.

A pilot study to examine association of BMI with functional class and 6 min walk distance in idiopathic and heritable PAH: Possible association with estrogen metabolism.

MacLean M, Pandya D, Swietlik E, Denver N, Mair K, Morrell N Pulm Circ. 2022; 12(3):e12139.

PMID: 36186719 PMC: 9510900. DOI: 10.1002/pul2.12139.

References

Simonneau G, Fartoukh M, Sitbon O, Humbert M, Jagot J, Herve P . Primary pulmonary hypertension associated with the use of fenfluramine derivatives. Chest. 1998; 114(3 Suppl):195S-199S. DOI: 10.1378/chest.114.3_supplement.195s. View

Peacock A, Murphy N, McMurray J, Caballero L, Stewart S . An epidemiological study of pulmonary arterial hypertension. Eur Respir J. 2007; 30(1):104-9. DOI: 10.1183/09031936.00092306. View

MacLean M, Deuchar G, Hicks M, Morecroft I, Shen S, Sheward J . Overexpression of the 5-hydroxytryptamine transporter gene: effect on pulmonary hemodynamics and hypoxia-induced pulmonary hypertension. Circulation. 2004; 109(17):2150-5. DOI: 10.1161/01.CIR.0000127375.56172.92. View

Humbert M, Deng Z, Simonneau G, Barst R, Sitbon O, Wolf M . BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives. Eur Respir J. 2002; 20(3):518-23. DOI: 10.1183/09031936.02.01762002. View

Hanna I, Dawling S, Roodi N, Guengerich F, Parl F . Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity. Cancer Res. 2000; 60(13):3440-4. View

Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V . Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med. 2006; 173(9):1023-30. DOI: 10.1164/rccm.200510-1668OC. View

Hemnes A, Maynard K, Champion H, Gleaves L, Penner N, West J . Testosterone negatively regulates right ventricular load stress responses in mice. Pulm Circ. 2012; 2(3):352-8. PMC: 3487303. DOI: 10.4103/2045-8932.101647. View

Dempsie Y, Morecroft I, Welsh D, MacRitchie N, Herold N, Loughlin L . Converging evidence in support of the serotonin hypothesis of dexfenfluramine-induced pulmonary hypertension with novel transgenic mice. Circulation. 2008; 117(22):2928-37. DOI: 10.1161/CIRCULATIONAHA.108.767558. View

Buters J, Doehmer J, Gonzalez F . Cytochrome P450-null mice. Drug Metab Rev. 1999; 31(2):437-47. DOI: 10.1081/dmr-100101929. View

10.

Archer S, Djaballah K, Humbert M, Weir K, Fartoukh M, DallAva-Santucci J . Nitric oxide deficiency in fenfluramine- and dexfenfluramine-induced pulmonary hypertension. Am J Respir Crit Care Med. 1998; 158(4):1061-7. DOI: 10.1164/ajrccm.158.4.9802113. View

11.

Abenhaim L, Moride Y, Brenot F, Rich S, Benichou J, Kurz X . Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. N Engl J Med. 1996; 335(9):609-16. DOI: 10.1056/NEJM199608293350901. View

12.

Thenappan T, Shah S, Rich S, Gomberg-Maitland M . A USA-based registry for pulmonary arterial hypertension: 1982-2006. Eur Respir J. 2007; 30(6):1103-10. DOI: 10.1183/09031936.00042107. View

13.

Rothman R, Baumann M . Therapeutic and adverse actions of serotonin transporter substrates. Pharmacol Ther. 2002; 95(1):73-88. DOI: 10.1016/s0163-7258(02)00234-6. View

14.

Rothman R, Cadet J, Dersch C, McCoy M, Lehrmann E, Becker K . Altered gene expression in pulmonary tissue of tryptophan hydroxylase-1 knockout mice: implications for pulmonary arterial hypertension. PLoS One. 2011; 6(3):e17735. PMC: 3064573. DOI: 10.1371/journal.pone.0017735. View

15.

Stoilov I, Akarsu A, Sarfarazi M . Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (Buphthalmos) in families linked to the GLC3A locus on chromosome 2p21. Hum Mol Genet. 1997; 6(4):641-7. DOI: 10.1093/hmg/6.4.641. View

16.

Reeve H, Archer S, Soper M, Weir E . Dexfenfluramine increases pulmonary artery smooth muscle intracellular Ca2+, independent of membrane potential. Am J Physiol. 1999; 277(3):L662-6. DOI: 10.1152/ajplung.1999.277.3.L662. View

17.

Lahm T, Albrecht M, Fisher A, Selej M, Patel N, Brown J . 17β-Estradiol attenuates hypoxic pulmonary hypertension via estrogen receptor-mediated effects. Am J Respir Crit Care Med. 2012; 185(9):965-80. PMC: 3359941. DOI: 10.1164/rccm.201107-1293OC. View

18.

Weng M, Raher M, Leyton P, Combs T, Scherer P, Bloch K . Adiponectin decreases pulmonary arterial remodeling in murine models of pulmonary hypertension. Am J Respir Cell Mol Biol. 2010; 45(2):340-7. PMC: 3175561. DOI: 10.1165/rcmb.2010-0316OC. View

19.

Higenbottam T, Marriott H, Cremona G, Laude E, Bee D . The acute effects of dexfenfluramine on human and porcine pulmonary vascular tone and resistance. Chest. 1999; 116(4):921-30. DOI: 10.1378/chest.116.4.921. View

20.

Austin E, Cogan J, West J, Hedges L, Hamid R, Dawson E . Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females. Eur Respir J. 2009; 34(5):1093-9. PMC: 3742124. DOI: 10.1183/09031936.00010409. View